Cargando…
Synergistic delivery of resveratrol and ultrasmall copper-based nanoparticles by aptamer-functionalized ultrasound nanobubbles for the treatment of nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is related to the production of reactive oxygen species (ROS) and oxidative stress, so antioxidant treatment can prevent its further development. Ultrasmall copper-based nanoparticles (CuNPs) have shown multiple enzyme-like activities for scavenging oxygen sp...
Autores principales: | Guo, Xinmin, Huang, Zhihui, Chen, Jialin, He, Kun, Lin, Jianru, Zhang, Hui, Zeng, Yanying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502034/ https://www.ncbi.nlm.nih.gov/pubmed/36160874 http://dx.doi.org/10.3389/fphys.2022.950141 |
Ejemplares similares
-
CAIX aptamer-functionalized targeted nanobubbles for ultrasound molecular imaging of various tumors
por: Zhu, Lianhua, et al.
Publicado: (2018) -
Apatinib-loaded lipid nanobubbles combined with ultrasound-targeted nanobubble destruction for synergistic treatment of HepG2 cells in vitro
por: Tian, Yuhang, et al.
Publicado: (2018) -
Editorial: Metabolism in nonalcoholic fatty liver disease
por: Najjar, Sonia Michael, et al.
Publicado: (2023) -
Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer
por: Wu, Meng, et al.
Publicado: (2018) -
Resveratrol inhibits nonalcoholic fatty liver disease in rats
por: Bujanda, Luis, et al.
Publicado: (2008)